Immunologix, Inc. — Form D/A
Immunologix, Inc. of CHARLESTON, SC, a company, filed a Form D amendment with the SEC on 2010-08-13. The offering totals $1.3M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-08-13
- Form: D/A
- Accession: 0001488257-10-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.3M
- Amount sold: $1.1M
- Remaining: $160K
- Investors: 21
- Date of first sale: 2010-03-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-140126
Issuer
- Name: Immunologix, Inc.
- CIK: 0001488257
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 645 MEETING STREET, SUITE 8, CHARLESTON, SC, 29403
- Phone: 843-789-5904
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Mark A Bartosh | Director | Charleston, SC |
| Robert A Kennedy | Director | Mount Laurel, NJ |
| Ryan N Fiorini | Director | Charleston, SC |
| Ryan N Fiorini | Executive Officer | Charleston, SC |
| Sam A Tetlow | Director | Chapel Hill, NC |
| Douglas M Carnes | Director | Charleston, SC |
| Douglas M Carnes | Executive Officer | Charleston, SC |
| Mark Bartosh | Director | Wayne, PA |
| Lloyd A Pearson | Director | Greenville, NC |
| Lloyd A Pearson | Executive Officer | Greenville, NC |
| Richard A McGregor | Director | Charleston, SC |
| Robert N Kennedy | Director | Charleston, SC |
Other filings by this issuer (2)
More